LinkedIn Profile

Access BioDelivery Sciences historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:bdsi 5755874 Jul 14th, 2022 12:00AM BioDelivery Sciences International 3.3K 88.00 Open Pharmaceuticals Jul 14th, 2022 05:56AM Jul 14th, 2022 05:56AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 13th, 2022 12:00AM BioDelivery Sciences International 3.3K 88.00 Open Pharmaceuticals Jul 13th, 2022 08:13AM Jul 13th, 2022 08:13AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 12th, 2022 12:00AM BioDelivery Sciences International 3.3K 88.00 Open Pharmaceuticals Jul 12th, 2022 05:58AM Jul 12th, 2022 05:58AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 11th, 2022 12:00AM BioDelivery Sciences International 3.3K 89.00 Open Pharmaceuticals Jul 11th, 2022 10:05AM Jul 11th, 2022 10:05AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 10th, 2022 12:00AM BioDelivery Sciences International 3.3K 89.00 Open Pharmaceuticals Jul 10th, 2022 06:41AM Jul 10th, 2022 06:41AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 9th, 2022 12:00AM BioDelivery Sciences International 3.3K 91.00 Open Pharmaceuticals Jul 9th, 2022 12:30PM Jul 9th, 2022 12:30PM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 8th, 2022 12:00AM BioDelivery Sciences International 3.3K 91.00 Open Pharmaceuticals Jul 8th, 2022 07:52AM Jul 8th, 2022 07:52AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 7th, 2022 12:00AM BioDelivery Sciences International 3.3K 91.00 Open Pharmaceuticals Jul 7th, 2022 07:52AM Jul 7th, 2022 07:52AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 6th, 2022 12:00AM BioDelivery Sciences International 3.3K 91.00 Open Pharmaceuticals Jul 6th, 2022 08:13AM Jul 6th, 2022 08:13AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology
nasdaq:bdsi 5755874 Jul 5th, 2022 12:00AM BioDelivery Sciences International 3.3K 92.00 Open Pharmaceuticals Jul 5th, 2022 06:05AM Jul 5th, 2022 06:05AM On March 22, 2022, Collegium Pharmaceutical completed its acquisition of BDSI through the merger of Purchaser with and into BDSI without a vote of BDSI's stockholders pursuant to Section 251(h) of the Delaware General Corporation Law (“DGCL”). As a result of the merger, BDSI is now wholly owned by Collegium. Open Open Raleigh North Carolina US 27612 BioDelivery Sciences Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.